CR Pharma IPO fuels expansion plans

China's second-largest drug manufacturer to raise funds for expansion amid industry consolidation.

CR Pharma IPO fuels expansion plans

China Resources Pharmaceutical Group CR Pharma has launched its Hong Kong initial public offering. The transaction has been eagerly awaited by investors because of its size and analyst expectations that the listed stock should perform better than other recent IPOs.

On Thursday the pharmaceutical arm of China Resources Holdings started bookbuilding for the transaction, which could raise as much as $1.57 billion $2 billion pre-greenshoe and $2.32 billion post-greenshoe.

Other billion-dollar...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition